A drug that can quickly reverse opioid overdoses could soon be available to anyone no prescription
A Food and Drug Administration advisory committee voted unanimously Wednesday to recommend that the agency allow a nasal spray version of naloxone, from Emergent Biosolutions, to be sold without a prescription.
Naloxone, also sold under the brand name Narcan, is a medication that has been used for decades to quickly reverse the effects of an opioid overdose, including prescription pain relievers, as well as heroin and fentanyl. In November, the FDA asked pharmaceutical companies that make naloxone to apply for over-the-counter approval.
Committee members said the move would save lives.
“For the good of the public and to save lives, I believe this drug should be available without a prescription as soon as possible,” said Dr. Katalin Roth, a professor of medicine at the George Washington University School of Medicine and Health Sciences. , after the vote.
Drug overdoses are now the leading cause of accidental death in the United States, according to the Centers for Disease Control and Preventionkilling more than 107,000 people in 2021. More than 80,000 of those deaths involved opioids.
“The risk of an opioid overdose is too great to prevent the drug from reaching the over-the-counter market,” said Jennifer Higgins, director of grants for the Center for Human Development, a nonprofit organization that provides community health services. in Springfield, Mass.
Currently, naloxone is only offered as a prescription drugHowever, many states have created workarounds that allow people to get the drug directly from pharmacists. It can also often be found at community centers, local health departments, and needle exchange programs.
Still, not all pharmacists keep the drug in stock and some patients may be embarrassed to interact with a pharmacist, FDA official Dr. Jody Green said during Wednesday’s meeting. And community centers that offer free naloxone to patients are often in limited supply, she added.
The panel’s recommendation will now go to the FDA, which is expected to make a final decision before March 29. If the agency meets approval, the drug could be sold in places like convenience stores, supermarkets, even vending machines.
As overdoses have become more common, so have naloxone prescriptions: The number of naloxone prescriptions increased from about 359,000 in 2017 to 1.5 million in 2021, according to to informational documents published by the FDA.
Over-the-counter nasal spray
The version of naloxone being considered for over-the-counter use is a single 4-milligram dose, administered as a nasal spray. It has been approved since 2015 for the emergency treatment of known or suspected opioid overdoses in people of all ages, including children.
On Wednesday, most committee members agreed that naloxone was safe to use without medical supervision. The most common side effects after using the drug were related to opioid withdrawal, according to a presentation at the meeting. If given to someone who is not experiencing an opioid overdose, the drug will have no effect.
Instead, most concerns were about the drug’s instruction label and how easy it is to use.
Ease of use is particularly important for young children because they may have to administer the drug to a parent and other loved one who has overdosed, said Dr. Leslie Walker, director of the department of pediatrics at the University of Washington. .
Most people use naloxone correctlythough mistakes sometimes happen like spraying the medication into the air, instead of into the nose, or not waiting the recommended two to three minutes before giving another dose.
Some people did not keep the device fully inserted into their nose during use, according to the agency, while others kept it upside down.
In an effort to make the nasal spray easier to use, Emergent representatives proposed a new label with a bright red background and bold black lettering. It contains instructions on how to use the medication, as well as the proper steps to take after administering naloxone, including calling 911.
Other panel members said they had concerns about supply issues because people could misuse it, wasting doses.
However, Elizabeth Coykendall, a patient representative for WakeMed Children’s PM Pediatrics Urgent Care in North Carolina, was confident that people could properly administer the medication.
“Giving them Narcan without a prescription will give them a better chance of staying alive,” he said.
CORRECTION (February 15, 2023 5:46 PM ET): An earlier version of this article erroneously stated the day the FDA advisory committee meeting took place. It was Wednesday, not Thursday.

